Suicidal Ideation and Self-Harm Risk Assessment

Suicidal ideation and self-harm risk assessment is the structured identification and gradation of suicidal thoughts, intent, plans, and self-harm behavior, using validated questions and scales to flag people who need urgent evaluation. Tools such as the Columbia-Suicide Severity Rating Scale (C-SSRS) and the brief Ask Suicide-Screening Questions (ASQ) provide consistent ways to ask about and rate suicide risk in clinical settings, with positive findings prompting a fuller safety evaluation.

Definition

The use of validated structured questions and rating scales (such as the C-SSRS and the ASQ) to detect and grade suicidal ideation, intent, planning, and self-harm behavior, with positive results prompting a comprehensive clinical risk evaluation rather than constituting that evaluation.

Scope

The topic covers the rationale, instruments, and measurement logic of suicide-risk screening and assessment, the distinction between screening and a full risk evaluation, and the contested evidence on routine general-population screening. It is framed as a preventive-services and measurement topic and does not provide crisis protocols, safety planning steps, or management guidance for any individual.

Core questions

• How does a brief suicide screen differ from a comprehensive suicide-risk assessment?
• What dimensions (ideation, intent, plan, behavior) do structured instruments grade, and why does grading matter?
• Why have guideline bodies found evidence insufficient for routine general-adult suicide screening?
• How are screening positives linked to timely, fuller evaluation and care?

Key concepts

• Suicidal ideation, intent, plan, and behavior
• Columbia-Suicide Severity Rating Scale (C-SSRS)
• Ask Suicide-Screening Questions (ASQ)
• Screening versus comprehensive risk assessment
• Severity and lethality gradation
• Linkage from positive screen to safety evaluation

Mechanisms

Structured suicide-risk instruments standardize how questions about ideation and behavior are asked and rated, separating the presence of thoughts from their severity, intensity, and any associated plan or attempt. The C-SSRS grades both ideation and behavior on ordered dimensions so that change and risk level can be tracked, while the ASQ is an ultra-brief set of questions designed to flag risk rapidly in busy clinical settings. A positive screen is not itself a risk determination: it triggers a comprehensive clinical assessment that integrates history, current state, and protective and precipitating factors.

Clinical relevance

Standardized suicide-risk questions are used across emergency, primary-care, and behavioral-health settings to ensure risk is asked about consistently. This entry describes how the instruments and the screen-to-assessment pathway are structured; it is educational and does not provide a clinical risk-stratification rule, safety plan, or management pathway for any individual, all of which require trained clinical judgement and current guidelines. People in crisis should seek immediate professional help.

Epidemiology

Suicidal ideation and self-harm are strongly associated with depression, anxiety, and substance use disorders, which is why suicide-risk assessment is grouped with behavioral-health screening. The US Preventive Services Task Force found the evidence insufficient to recommend for or against routine suicide-risk screening in the general adult population, even while recommending depression screening, reflecting uncertainty about benefits and harms of stand-alone suicide screening.

Evidence & guidelines

The C-SSRS (Posner 2011) is a widely used instrument that grades the severity of suicidal ideation and behavior, and the ASQ (Horowitz 2012) is a brief screen validated initially in pediatric emergency settings. The USPSTF (2023) reviewed suicide-risk screening alongside depression and concluded the evidence was insufficient for routine general-adult screening, underscoring that screening tools are aids to, not substitutes for, comprehensive clinical assessment.

History

Structured suicide-risk measurement advanced as research-derived scales moved into clinical use, with the C-SSRS introduced in 2011 to standardize the rating of ideation and behavior across settings and the ASQ validated in 2012 to provide an ultra-brief emergency-department screen. Preventive-services bodies subsequently weighed whether such screening should be routine in general populations, leaving the question open.

Debates

Should suicide-risk screening be routine for all adults?

The USPSTF found insufficient evidence to recommend for or against universal suicide-risk screening in the general adult population, with uncertainty about whether screening reduces suicide attempts or deaths and about potential harms, so routine stand-alone screening remains contested.

Key figures

• Kelly Posner
• J. John Mann
• Barbara Stanley
• Lisa M. Horowitz

Seminal works

• posner-2011-cssrs
• horowitz-2012-asq

Frequently asked questions

Is a suicide-risk screen the same as a full risk assessment?

No. A screen, such as the ASQ, rapidly flags possible risk; a comprehensive assessment, which structured tools like the C-SSRS support, integrates the severity of ideation and behavior with clinical history and context and requires trained judgement.

Why do guidelines hesitate to recommend universal suicide screening?

Preventive-services reviews have found insufficient evidence that routine general-adult suicide screening reduces attempts or deaths, and they weigh potential harms, so they neither recommend for nor against it while still recommending depression screening.